Geron | GERN - Market Capitalization

Stock Price
1.50
Daily Change
0 0%
Monthly
-4.46%
Yearly
5.63%
Q2 Forecast
1.47

Geron reported $903.7M in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Amgen USD 176.25B 24.32B Dec/2025
Bio Techne USD 9.16B 502M Dec/2025
Cassava Sciences USD 96M 45M Dec/2025
Cytokinetics USD 7.77B 1.19B Dec/2025
Esperion Therapeutics USD 885M 351M Dec/2025
Exelixis USD 11.75B 959M Dec/2025
Genmab DKK 20.48B 1.02B Dec/2025
Geron USD 843M 31M Dec/2025
Gilead Sciences USD 166.62B 14.34B Apr/2026
Incyte USD 19.39B 2.83B Dec/2025
MacroGenics USD 102M 4M Dec/2025
Novartis USD 292.21B 26.55B Dec/2025
Novavax USD 1.09B 316M Dec/2025